Overview of Medical Devices Regulations Velocity Science Sarah Chandler A/Manager, Device Licensing Services Division Medical Devices Bureau Health Canada.

Slides:



Advertisements
Similar presentations
Health Products and Food Branch Direction générale des produits de santé et des aliments The Canadian Medical Devices Regulatory Program CESO Conference.
Advertisements

Your Health and Votre santé et votre Safety... Our priority Securité… notre priorité Medical Device Establishment Licensing Nick Shipley Manager, Establishment.
Regulatory Pathway for Platform Technologies
The regulation of medical devices in Australia. Overview Comparing medicines and medical devices What is a medical device? Statistics on patients requiring.
Overview of Device Regulations David Arvelo Small Business Representative.
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
Australian Guidance Document Number xx Cathy Thomas Professional Representation OT Australia WA.
SALDA In Vitro Diagnostics in South Africa Welcome 5 November 2014 Portfolio Committee Bill
Accreditation 1. Purpose of the Module - To create knowledge and understanding on accreditation system - To build capacity of National Governments/ focal.
Chapter 22 Regulatory & Advisory Agencies Copyright 2003, Elsevier Science (USA). All rights reserved. No part of this product may be reproduced or transmitted.
Special Topics in IND Regulation
Medical Devices Approval Process
Entering the North American Market
FDA Basics: Tissue Safety
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Therapeutic Goods Administration An introduction to the work of Australia’s regulator of therapeutic goods.
James Williams – BA, BSc, JD, MSc, Privacy and Security Consultant, Blue Pebble, Phd candidate, University of Victoria.
Canada Consumer Product Safety Act An Overview Graham Stewart Health Canada.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
DIVISION OF LICENSING & CERTIFICATION, BUREAU OF HEALTH SYSTEMS (BHS) - MDCH (517) Fax (517)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Clinical Trial Review and Approval: New Regulations and their implications Siddika Mithani, Ph.D Clinical Trials & Special Access Programme Therapeutic.
Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.
Nuclearsafety.gc.ca Joint Congress on Medical Imaging and Radiation Sciences May 28, 2015 e-Doc CNSC Administrative Monetary Penalties Overview.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
SALDA Presentation to the Honourable Portfolio Committee on Health National Health Act Amendment Bill B March 2012.
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
Overview of FDA's Regulatory Framework for PET Drugs
Center for Drug Evaluation and Research (CDER) Tanya Eberle Kamal Diar David Clements.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
1 BIORESEARCH MONITORING AND IN VITRO DIAGNOSTICS SYBIL WELLSTOOD, PH.D. OFFICE OF COMPLIANCE DIVISION OF BIORESEARCH MONITORING.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
Product Recall Laws in China Xiangwen Liu Partner King & Wood PRC Lawyers.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
Regulatory Updates Health Sciences Authority Singapore
Contingent Workforce: Cerner Quality System & Regulations
Executive Director, Registrar Corp
Dental Standards & Testing Methods

Division of Cardiovascular Devices
Premarket Notification 510(k) process
Kimby N. Barton Interim Director Medical Devices Bureau
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
Standardization in the Beauty and Wellness Sector
Introduction to GMP.
Proposal for a Regulation on medical devices and Proposal for a Regulation on in vitro diagnostic medical devices Key Provisions and GIRP Assessment.
Combination products The paradigm shift
Software & Apps - to be a medical device or not
Medical Devices.
OHSC 2018 CONSULTATIVE WORKSHOPS CERTIFICATION AND ENFORCEMENT
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Opening an IND: Investigator Perspective
Regulation in South-East Asia Joint Drugs Controller (India)
Compounded Drugs and Lack of Premarket FDA-Approval
Regulatory Perspective of the Use of EHRs in RCTs
Panel discussion GMP inspection process – Health Canada
Presentation transcript:

Overview of Medical Devices Regulations Velocity Science Sarah Chandler A/Manager, Device Licensing Services Division Medical Devices Bureau Health Canada

Medical Device Stakeholders 2

Brief History of the Canadian Medical Device Regulatory Framework 3 Medical Devices Regulations (MDR) come into force on September MDR amended to include premarket review for some devices Medical Devices Review Committee (MDRC) created to assess regulation MDRC publish their report which includes several recommendations The Medical Devices Bureau is unified under one Directorate The new MDR comes into effect, making licensing a requirement Greater than Medical Device Licences renewed.

Regulatory Framework Canada has incorporated successful elements from other regulatory systems into our own regulations:  Risk Based Classification System  Quality System Requirement  Pre-Market Licensing  Post-Market Regulation 4

Regulatory Tools 5

Health Canada’s Medical Devices Program HEALTH PRODUCTS & FOOD BRANCH (HPFB) 6 ATLANTIC BC ONTARIO PRAIRIE QUEBEC HPFBI SERVICE DELIVERY FUNCTION (FIELD INSPECTION) REGIONS & PROGRAMS BUREAU RAPB RISK MANAGEMENT BUREAU LICENSING & INSPECTION BUREAU POST-MARKET SAFETY SURVEILLANCE, ASSESSMENT OF SIGNALS & SAFETY TRENDS, AND RISK COMMUNICATIO NS POST-MARKET COMPLIANCE MONITORING AND ENFORCEMENT ACTIVITIES SUPPORTED BY AN ESTABLISHMENT LICENSING SYSTEM THERAPEUTIC PRODUCTS DIRECTORATE TPD MARKETED HEALTH PRODUCTS DIRECTORATE MHPD HEALTH PRODUCTS & FOOD BRANCH INSPECTORATE HPFBI PRE-MARKET ASSESSMENT OF MEDICAL DEVICE SAFETY, EFFECTIVENESS & REGULATORY COMPLIANCE, SUPPORTED BY A LICENSING SYSTEM INTENDED TO REGULATE MARKET ACCESS ESTABLISHMENT LICENSING UNIT MEDICAL DEVICES BUREAU BORDER INTEGRITY UNIT MARKETED PHARMA & MD BUREAU MEDICAL DEVICES COMPLIANCE UNIT

What is a Device? Section 2 of the Food & Drugs Act: 7

What is a Medical Device? Section 1 of the Medical Devices Regulations: 8

Regulatory Provisions All devices offered for sale in Canada must comply with the Food and Drugs Act: –Cannot advertise or represent by label a treatment for a Schedule A disease or disorder (Section 3) –Cannot sell or advertise a device that may cause harm –Cannot sell or advertise a device in a misleading or deceptive way All medical devices (those used on human beings) must also comply with the Medical Devices Regulations 9

Regulatory Provisions The Regulations apply to: –The sale and advertising for sale of a medical device –The importation of a medical device for sale or for use on individuals, other than importation for personal use Manufacturers of medical devices apply to Health Canada to receive either a Licence or an Authorization to sell their devices. 10

Regulatory Provisions A manufacturer: –Sells a medical device under their own name, trade- mark, design, trade name or other name owned or controlled by the person –Is responsible for designing, manufacturing, assembling, processing, labelling, packaging, refurbishing or modifying the device, assigning it a purpose –Performs or has someone perform on their behalf Manufacturer = Name on the label 11

Classification of Medical Devices MDR sets out a system for classifying medical devices into one of four classes. Low RiskHigh RiskModerate Risk Class IClass IIClass IIIClass IV Increasing Regulatory Oversight 12

Class I - Premarket regulatory oversight based on establishment licensing - Post-market oversight based on compliance to applicable sections of the MDR Class II - Certification that device is manufactured according to international Quality Management System standard (ISO 13485). - Manufacturer’s attestation that device satisfies the safety, effectiveness requirements in MDR. Label reviewed. Class III - Certification that device is designed & manufactured according to ISO Evidence of safety, effectiveness & labelling reviewed to validate compliance with MDR. Class IV - Certification that device is designed & manufactured according to ISO Evidence of safety, effectiveness & labelling reviewed to validate compliance with MDR. More stringent review than Class III. Premarket regulatory oversight based on licensing system. Market authorization is granted to manufacturers who demonstrate conformity to requirements set out in MDR. Post-market surveillance intended to enforce and promote compliance with MDR Premarket oversight with establishment licensing Post-market surveillance to promote compliance with MDR Risk-Based Regulatory System 13

Quality Management System ISO 13485:2003 Quality Management System Certificate Recognized Registrars: BSI (US) Dekra (Netherlands) Intertek (CN) G-MED (France) LRQA (US) NSAI (Ireland) SGS (UK) SAI (Australia) DQS (GER) LGA (GER) TUV-N/S (US) TGA (Australia) UL (USA) TUV (US) 14

Application Process – Class II 15

Application Process – Class III & IV 16

REQUIREMENTS Class I Class II Class III Class IV Medical Device Licence (s.26) (manufacturer) exempt must hold active licence Safety & Effectiveness (s ) (manufacturer) keep objective evidence keep objective evidence & provide attestation submit objective evidence for review Labelling (s ) (all parties engaged in importation or sales activities) compliant label (submit for review) compliant label (submit for review) compliant label (submit review) Quality Management System Certificate (manufacturer) exempt ISO certified (for manufacturing activities) ISO certified (for design and manufacturing activities) ISO certified (for design and manufacturing activities) Distribution Records (s ) (manufacturer, importer & distributor) maintain record Complaint Handling (s ) (manufacturer, importer & distributor) maintain record Mandatory Problem Reporting (s ) (manufacturer & importer) submit preliminary & final report Recall (s ) (manufacturer & importer) submit recall notice Establishment Licence (s. 44) (class I manufacturer, importer & distributor) must hold active licence must hold active licence (to import/distribute other manufacturers’ devices) must hold active licence (to import/distribute other manufacturers’ devices) must hold active licence (to import/distribute other manufacturers’ devices)

Premarket Review Document Requirements 18

Classification of Medical Devices To determine the classification of a device, you must apply all of the rules in Schedule 1 of the Medical Devices Regulations. You must consider the labelled indications for use, or claims made for the device. 19

Classification of Medical Devices Non In vitro Diagnostic Devices –Large number of variables –Rapid technological advances –Classification criteria based on: The human body Inherent device related potential hazards Customary device use (O.R., I.C.U., N.I.C.U.) 20

Definitions “Invasive device” means a medical device that is intended to come into contact with the surface of the eye or penetrate the body, either through a body orifice or through the body surface. “Surgically invasive device” means an invasive device that is intended to enter the body through an artificially created opening that provides access to body structures and fluids. 21

Definitions “Central cardiovascular system” means the heart, pericardium, pulmonary veins, pulmonary arteries, cardiac veins, coronary arteries, common carotid arteries, cerebral arteries, common carotid arteries, cerebral arteries, brachiocephalic artery, aorta, inferior and superior vena cava, renal arteries, iliac arteries and femoral arteries. “Surgical or dental instrument” means a reusable medical device that is intended for surgical or dental use, including cutting, drilling, sawing, scraping, clamping, hammering, puncturing, dilating, retracting or clipping, without connection to an active device. 22

Definitions “Active device” means a medical device that depends for its operation on a source of energy other than energy generated by the human body or gravity. A medical device that transmits or withdraws energy or a substance to or from a patient without substantially altering the energy or the substance is not an active device. 23

Definitions “Active Diagnostic Device” means an active device that, whether used alone or in combination with another medical device, is intended to supply information for the purpose of detecting, monitoring or treating a physiological condition, state of health, illness or congenital deformity. “Active Therapeutic Device” means an active device that, whether used alone or in combination with another medical device, is intended to support, modify, replace or restore a biological function or structure for the purpose of treating or mitigating an illness or injury or a symptom of an illness or injury. 24

Classification of Medical Devices In vitro Diagnostic Devices (IVDDs) –IVDD means a medical device that is intended to be used in vitro for the examination of specimens taken from the body. –The greater the risk associated with a false positive/false negative, the higher the Class. 25

Definitions “Near patient IVDD” means an in vitro diagnostic device that is intended for use outside a laboratory, for testing at home or at the point of care, such as a pharmacy, a health care professional’s office or the bedside. 26

Classification? Bandage Antimicrobial Wound Dressing 27

Classification? X-Ray Computed Tomography Scanner Portable X-Ray Machine 28

Classification? Natural Absorbable Suture X 29

Classification? Oral Thermometer X 30

Classification? Drugs of Abuse Test Cassette (For laboratory use only) Drugs of Abuse Test Cup (For point of care use) 31

Classification? Pregnancy Test 32

Overview Class I (low risk) – Class IV (high risk) Pre-market resources apply primarily to Class III & IV Product licensing applies to Class II, III & IV Quality Management System requirements apply to Class II, III & IV Post-market requirements apply to all classes 33

Other Regulatory Provisions Part 2: Special Access Programme –Access to custom-made devices (other than mass- produced device) –Access to devices for emergency use or if conventional therapies have failed, are unavailable or are unsuitable –Applications in prescribed format must be received from a health care professional –Authorization for sale granted to manufacturer of the device 34

Other Regulatory Provisions Part 3: Investigational Testing –Grants authorization to conduct clinical trials involving human subjects –Applications are received from the manufacturer, including a risk assessment and detailed protocol –Allows manufacturers to acquire evidence of safety and effectiveness as required by Sections of the Regulations 35

Interesting Statistics 36

Interesting Statistics 37

Thank You! 38